Embecta

Update in progress

EMBC (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryMedical Instruments & Supplies

Embecta Corp. is a medical device company focused on diabetes care. It offers pen needles, syringes, safety injection devices, and digital tools to help people manage diabetes in the United States and around the world. The company sells primarily to wholesalers and distributors. Formerly Berra Newco, Inc., Embecta was founded in 1924 and is headquartered in Parsippany, New Jersey.

Company score

Sentiment: 0.45; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.01; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.23; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.13; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.10; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.28; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive

Company

MarketNasdaqGS (NMS)
LocationUnited States
CEOMr. Devdatt Kurdikar Ph.D.
Founded1924
Employees1,850
Websitewww.embecta.com

Identifiers

ISINUS29082K1051
FIGIBBG014L7D4G1
CUSIP29082K105
CIK0001872789